|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Current assets: | |||
| Cash and Cash Equivalents | |||
| Prepaid insurance - Current | |||
| Total current assets | |||
| Deferred offering costs | |||
| Prepaid insurance - Non-Current | |||
| Marketable securities held in Trust Account | |||
| Deferred offering costs | |||
| TOTAL ASSETS | |||
| LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT | |||
| Current liabilities: | |||
| Accrued offering costs | |||
| Accounts payable | |||
| Accrued expenses | |||
| Due to related party | |||
| Promissory note - related party | |||
| Total current liabilities | |||
| Deferred underwriting fee payable | |||
| Advisory fee payable | |||
| Total Liabilities | |||
| Class A ordinary shares subject to possible redemption, 34,500,000 shares at redemption value of $10.14 per share at June 30, 2026 | |||
| Common Class A | |||
| Total class A ordinary shares subject to possible redemption, 34,500,000 shares at redemption value of $10.14 per share at June 30, 2026 | |||
| Shareholders’ Deficit | |||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2026 and December 31, 2025 | |||
| Common stock value | |||
| Common Class A | |||
| Common Class B | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| TOTAL LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT |
Loading...
